<li>amiodarone<p>amiodarone will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>amitriptyline<p>amitriptyline, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>amitriptyline, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>amoxapine<p>amoxapine, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>amoxapine, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>promethazine, amoxapine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>asenapine<p>asenapine will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>ashwagandha<p>ashwagandha increases effects of promethazine by pharmacodynamic synergism. Minor/Significance Unknown. May enhance CNS depression.</p></li><li>atropine<p>promethazine increases toxicity of atropine by unknown mechanism. Minor/Significance Unknown.</p></li><li>atropine iv/im<p>promethazine increases toxicity of atropine iv/im by unknown mechanism. Minor/Significance Unknown.</p></li><li>attapulgite<p>attapulgite decreases levels of promethazine by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>benazepril<p>promethazine increases effects of benazepril by unspecified interaction mechanism. Minor/Significance Unknown. Enhanced hypotensive effects.</p></li><li>brimonidine<p>brimonidine increases effects of promethazine by pharmacodynamic synergism. Minor/Significance Unknown. Increased CNS depression.</p></li><li>bupropion<p>promethazine increases toxicity of bupropion by unspecified interaction mechanism. Minor/Significance Unknown. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>captopril<p>promethazine increases effects of captopril by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>celecoxib<p>celecoxib will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>chasteberry<p>chasteberry decreases effects of promethazine by pharmacodynamic antagonism. Minor/Significance Unknown. (Theoretical interaction).</p></li><li>chloroquine<p>chloroquine will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.<span><br><br></span>chloroquine increases levels of promethazine by decreasing metabolism. Minor/Significance Unknown.</p></li><li>cimetidine<p>cimetidine will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>clomipramine<p>clomipramine, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>clomipramine, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>darifenacin<p>darifenacin will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>desipramine<p>desipramine, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>desipramine, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>diphenhydramine<p>diphenhydramine will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>dosulepin<p>dosulepin, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>dosulepin, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>doxepin<p>doxepin, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>doxepin, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>dronedarone<p>dronedarone will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>duloxetine<p>duloxetine will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>enalapril<p>promethazine increases effects of enalapril by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>ethanol<p>ethanol, promethazine.
Either increases toxicity of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive CNS depression.</p></li><li>eucalyptus<p>promethazine and eucalyptus both increase  sedation. Minor/Significance Unknown.</p></li><li>famciclovir<p>promethazine, famciclovir. aldehyde dehydrogenase inhibition. Minor/Significance Unknown. The conversion of 6-deoxy penciclovir to penciclovir is catalyzed by aldehyde oxidase. Interactions with other drugs metabolized by this enzyme and/or inhibiting this enzyme could potentially occur. Clinical interaction studies of famciclovir with promethazine did not show relevant effects on the formation of penciclovir.</p></li><li>fosinopril<p>promethazine increases effects of fosinopril by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>glycopyrrolate<p>promethazine increases toxicity of glycopyrrolate by unknown mechanism. Minor/Significance Unknown.</p></li><li>glycopyrrolate inhaled<p>promethazine increases toxicity of glycopyrrolate inhaled by unknown mechanism. Minor/Significance Unknown.</p></li><li>haloperidol<p>haloperidol will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>imatinib<p>imatinib will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>imidapril<p>promethazine increases effects of imidapril by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>imipramine<p>imipramine, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>imipramine, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>lisinopril<p>promethazine increases effects of lisinopril by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>lofepramine<p>lofepramine, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>lofepramine, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>maprotiline<p>maprotiline, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>maprotiline, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>maraviroc<p>maraviroc will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>marijuana<p>marijuana will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>metyrapone<p>promethazine decreases effects of metyrapone by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>metyrosine<p>metyrosine increases toxicity of promethazine by pharmacodynamic synergism. Minor/Significance Unknown. Increased extrapyramidal symptoms.</p></li><li>mianserin<p>mianserin, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>mianserin, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>mibefradil<p>mibefradil will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>moexipril<p>promethazine increases effects of moexipril by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>nettle<p>nettle increases effects of promethazine by pharmacodynamic synergism. Minor/Significance Unknown. (High dose nettle; theoretical interaction) May enhance CNS depression.</p></li><li>nilotinib<p>nilotinib will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>nortriptyline<p>nortriptyline, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>nortriptyline, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>oxybutynin<p>oxybutynin increases toxicity of promethazine by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>oxybutynin topical<p>oxybutynin topical increases toxicity of promethazine by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>oxybutynin transdermal<p>oxybutynin transdermal increases toxicity of promethazine by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>parecoxib<p>parecoxib will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>perindopril<p>promethazine increases effects of perindopril by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>perphenazine<p>perphenazine will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>protriptyline<p>protriptyline, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>protriptyline, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>pyrimethamine<p>pyrimethamine increases levels of promethazine by decreasing metabolism. Minor/Significance Unknown.</p></li><li>quinacrine<p>quinacrine will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>quinapril<p>promethazine increases effects of quinapril by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>ramipril<p>promethazine increases effects of ramipril by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>ranolazine<p>ranolazine will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>ritonavir<p>ritonavir will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>sage<p>promethazine and sage both increase  sedation. Minor/Significance Unknown.</p></li><li>sertraline<p>sertraline will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>siberian ginseng<p>siberian ginseng increases effects of promethazine by pharmacodynamic synergism. Minor/Significance Unknown. May enhance CNS depression.</p></li><li>thioridazine<p>thioridazine will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>tipranavir<p>tipranavir will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>trandolapril<p>promethazine increases effects of trandolapril by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>trazodone<p>trazodone, promethazine.
Either increases toxicity of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive hypotensive effects.<span><br><br></span>trazodone, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li><li>trimipramine<p>trimipramine, promethazine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown. Additive anticholinergic effects.<span><br><br></span>trimipramine, promethazine.
Either increases levels of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive anticholinergic effects.</p></li>